Semra Aydin

2.0k total citations · 1 hit paper
34 papers, 1.5k citations indexed

About

Semra Aydin is a scholar working on Hematology, Genetics and Physiology. According to data from OpenAlex, Semra Aydin has authored 34 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 12 papers in Genetics and 12 papers in Physiology. Recurrent topics in Semra Aydin's work include Chronic Lymphocytic Leukemia Research (12 papers), Calcium signaling and nucleotide metabolism (12 papers) and Acute Myeloid Leukemia Research (9 papers). Semra Aydin is often cited by papers focused on Chronic Lymphocytic Leukemia Research (12 papers), Calcium signaling and nucleotide metabolism (12 papers) and Acute Myeloid Leukemia Research (9 papers). Semra Aydin collaborates with scholars based in Italy, Germany and United States. Semra Aydin's co-authors include Fabio Malavasi, Silvia Deaglio, Tiziana Vaisitti, Enza Ferrero, Ada Funaro, Erika Ortolan, Alberto L. Horenstein, L Bergui, Giovanni D’Arena and Lisa Bonello and has published in prestigious journals such as Physiological Reviews, Blood and PLoS ONE.

In The Last Decade

Semra Aydin

33 papers receiving 1.5k citations

Hit Papers

Evolution and Function of the ADP Ribosyl Cyclase/CD38 Ge... 2008 2026 2014 2020 2008 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Semra Aydin Italy 14 660 481 432 383 343 34 1.5k
Antonella Chillemi Italy 15 599 0.9× 85 0.2× 393 0.9× 295 0.8× 410 1.2× 21 1.1k
Valeria Quarona Italy 13 564 0.9× 76 0.2× 379 0.9× 256 0.7× 378 1.1× 16 1.0k
Gianluca Zaccarello Italy 8 383 0.6× 41 0.1× 217 0.5× 189 0.5× 240 0.7× 11 683
Marilena Ciciarello Italy 21 98 0.1× 153 0.3× 233 0.5× 726 1.9× 279 0.8× 41 1.2k
Theodore Ho United States 8 51 0.1× 193 0.4× 299 0.7× 784 2.0× 62 0.2× 12 1.5k
Sara Trabanelli Switzerland 21 118 0.2× 76 0.2× 1.0k 2.4× 225 0.6× 437 1.3× 40 1.5k
H.‐P. Hartung Germany 18 62 0.1× 31 0.1× 352 0.8× 340 0.9× 308 0.9× 62 1.6k
Ritu Malhotra United States 10 52 0.1× 58 0.1× 128 0.3× 981 2.6× 36 0.1× 19 1.4k
Tony Roscioli Australia 24 30 0.0× 152 0.3× 141 0.3× 877 2.3× 64 0.2× 85 1.7k
Alexander Faußner Germany 19 46 0.1× 433 0.9× 206 0.5× 390 1.0× 115 0.3× 43 872

Countries citing papers authored by Semra Aydin

Since Specialization
Citations

This map shows the geographic impact of Semra Aydin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Semra Aydin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Semra Aydin more than expected).

Fields of papers citing papers by Semra Aydin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Semra Aydin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Semra Aydin. The network helps show where Semra Aydin may publish in the future.

Co-authorship network of co-authors of Semra Aydin

This figure shows the co-authorship network connecting the top 25 collaborators of Semra Aydin. A scholar is included among the top collaborators of Semra Aydin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Semra Aydin. Semra Aydin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aydin, Semra, Jennifer Schmitz, Chiara Maria Dellacasa, et al.. (2024). WT1 Expression Is Associated with Poor Overall Survival after Azacytidine and DLI in a Cohort of Adult AML and MDS Patients. Cancers. 16(17). 3070–3070. 1 indexed citations
2.
Aydin, Semra, Roberto Passera, Marco Cerrano, et al.. (2023). Combining the HCT-CI, G8, and AML-Score for Fitness Evaluation of Elderly Patients with Acute Myeloid Leukemia: A Single Center Analysis. Cancers. 15(4). 1002–1002. 7 indexed citations
3.
Frairia, Chiara, Alessandro Busca, Silvia Corcione, et al.. (2023). Levofloxacin prophylaxis omission in acute myeloid leukemia during post induction aplasia: a single center study. Mediterranean Journal of Hematology and Infectious Diseases. 15(1). e2023022–e2023022. 5 indexed citations
4.
Aydin, Semra, Roberto Passera, Chiara Maria Dellacasa, et al.. (2022). Sorafenib maintenance after hematopoietic stem cell transplantation improves outcome of FLT3–ITD-mutated acute myeloid leukemia. International Journal of Hematology. 116(6). 883–891. 6 indexed citations
5.
Aydin, Semra, Stefano D’Ardìa, Massimo Massaia, et al.. (2021). CD157 signaling promotes survival of acute myeloid leukemia cells and modulates sensitivity to cytarabine through regulation of anti-apoptotic Mcl-1. Scientific Reports. 11(1). 21230–21230. 8 indexed citations
6.
Busca, Alessandro, Chiara Maria Dellacasa, Luisa Giaccone, et al.. (2018). Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(8). 1765–1770. 16 indexed citations
7.
Busca, Alessandro, Roberto Passera, Enrico Maffini, et al.. (2018). Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting. Bone Marrow Transplantation. 53(10). 1304–1310. 9 indexed citations
9.
Brunello, Lucia, Roberto Passera, Chiara Maria Dellacasa, et al.. (2018). Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients. Annals of Hematology. 97(11). 2205–2215. 4 indexed citations
10.
Frairia, Chiara, Semra Aydin, Ernesta Audisio, et al.. (2017). Post-remissional and pre-transplant role of minimal residual disease detected by WT1 in acute myeloid leukemia: A retrospective cohort study. Leukemia Research. 61. 10–17. 19 indexed citations
11.
Giaccone, Luisa, Moreno Festuccia, Francesco Zallio, et al.. (2017). Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma. Bone Marrow Transplantation. 52(8). 1208–1211. 5 indexed citations
12.
Castellino, Alessia, Stefano Guidi, Antonella Gozzini, et al.. (2017). Late-onset hepatic veno-occlusive disease after allografting: report of two cases with atypical clinical features successfully treated with defibrotide.. Mediterranean Journal of Hematology and Infectious Diseases. 10(1). 2018001–2018001. 4 indexed citations
13.
Hanoun, Maher, Lewin Eisele, Masako Suzuki, et al.. (2012). Epigenetic Silencing of the Circadian Clock Gene CRY1 is Associated with an Indolent Clinical Course in Chronic Lymphocytic Leukemia. PLoS ONE. 7(3). e34347–e34347. 41 indexed citations
14.
Aydin, Semra, Florian Grabellus, Lewin Eisele, et al.. (2011). Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model. European Journal Of Haematology. 87(1). 10–19. 21 indexed citations
15.
Vaisitti, Tiziana, Semra Aydin, Davide Rossi, et al.. (2010). CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells. Leukemia. 24(5). 958–969. 82 indexed citations
16.
Deaglio, Silvia, Semra Aydin, Tiziana Vaisitti, L Bergui, & Fabio Malavasi. (2008). CD38 at the junction between prognostic marker and therapeutic target. Trends in Molecular Medicine. 14(5). 210–218. 50 indexed citations
17.
Malavasi, Fabio, Silvia Deaglio, Enza Ferrero, et al.. (2007). CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity.. DIGITAL.CSIC (Spanish National Research Council (CSIC)). 12(11-12). 334–41. 65 indexed citations
18.
D’Arena, Giovanni, Michela Tarnani, Carlo Rumi, et al.. (2007). Prognostic significance of combined analysis of ZAP‐70 and CD38 in chronic lymphocytic leukemia. American Journal of Hematology. 82(9). 787–791. 33 indexed citations
19.
Aydin, Semra, Ulrich Dührsen, & Holger Nückel. (2007). Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin’s lymphoma: a single-centre study of 20 patients. Annals of Hematology. 86(4). 271–276. 6 indexed citations
20.
Deaglio, Silvia, Tiziana Vaisitti, Semra Aydin, Enza Ferrero, & Fabio Malavasi. (2006). In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia. Blood. 108(4). 1135–1144. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026